Неалкогольная жировая болезнь печени | страница 43



58. Castro-Quezada L, Sânchez-Villegas A., Estruch R., et al. A High Dietary Glycémie Index Increases Total Mortality in a Mediterranean Population at High Cardiovascular Risk. Gorlova OY, ed. PLoS ONE. 2014;9(9):el07968. doi:10.1371/ journal.pone.0107968.

59. Zelber-Sagi S., Godos J., Salomone F. Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials. Therapeutic Advances in Gastroenterology. 2016;9(3):392–407. doi:10.1177/ 1756283X16638830.

60. Jesch E.D., Carr T.P. Food Ingredients That Inhibit Cholesterol Absorption. Preventive Nutrition and Food Science. 2017;22(2):67–80. doi:10.3746/pnf.2017.22.2.67.

61. Lefebvre P., Cariou B., Lien F. et al. Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev. 2009 Jan;89(l):147-91. doi: 10.1152/physrev.00010.2008.

62. Watanabe M., Houten S.M., Mataki C. et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature. 2006 Jan 26;439(7075):484-9.

63. Willett W.C., Sacks F., Trichopoulou A.,et al. Mediterranean diet pyramid: a cultural model for healthy eating // Am J Clin Nutr. 1995 Jun;61(6 Suppl):1402S-1406S.

64. WHO/FAO (2003) Diet nutrition and the prevention of chronic diseases. Geneva, Switzerland. Available at www.who.int.

65. Hu F.B., Willett W.C. (2002) Optimal diets for prevention of coronary heart disease. JAMA. 2002 Nov 27; 288(20):2569-78. Review.

66. Estruch R., Ros E., Salas-Salvadô J. et al. PREDIMED Study Investigators. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013 Apr 4; 368(14):1279-90.

67. Gunge V.B., Andersen I., Куш C., et al. Adherence to a healthy Nordic food index and risk of myocardial infarction in middle-aged Danes: the diet, cancer and health cohort study. Eur J Clin Nutr. 2017 May;71(5):652–658. doi: 10.1038/ ejcn.2017.1. Epub 2017 Mar 1.

68. Sofi F., Casini A. Mediterranean diet and nonalcoholic fatty liver disease: New therapeutic option around the corner? World Journal of Gastroenterology: WJG. 2014;20 (23):7339–7346. doi:10.3748/wjg.v20.i23.7339.

69. Eckard C., Cole R., Lockwood J., et al. Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial. Therapeutic Advances in Gastroenterology. 2013;6(4):249–259. doi:10.1177/ 1756283X13484078.

70. Tzima N., Pitsavos C., Panagiotakos D.B. et al. Adherence to the Mediterranean diet moderates the association of aminotransferases with the prevalence of the metabolic syndrome; the ATTICA study. Nutr Metab (bond). 2009 Jul 30; 6():30.